CHRONIC WEIGHT MANAGEMENT
Clinical trials for CHRONIC WEIGHT MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new CHRONIC WEIGHT MANAGEMENT trials appear
Sign up with your email to follow new studies for CHRONIC WEIGHT MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot for obesity shows promise in early trial
Disease control CompletedThis study tested a new injectable drug called ASC30 in 115 adults with obesity. The goal was to check its safety, how the body processes it, and its effect on weight. Participants received either the drug or a placebo, and researchers monitored side effects and weight changes ov…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE1, PHASE2 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New pill shows promise for shedding pounds in obesity trial
Disease control CompletedThis study tested a new drug called aleniglipron (GSBR-1290) to help people with obesity or overweight lose weight. About 85 adults took either the drug or a placebo for 44 weeks, along with diet and exercise. The main goal was to check safety and side effects, while also measuri…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New obesity combo drug tested in small safety study
Disease control CompletedThis Phase 1 trial tested a new drug called ASC47, given as a shot under the skin, combined with the weight-loss drug semaglutide in 28 adults with obesity. The study was double-blind and placebo-controlled, meaning some participants got a dummy shot. The main goal was to check s…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE1 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New daily pill shows promise for weight loss in early trial
Disease control CompletedThis completed Phase IIa study tested a daily pill called ASC30 in 125 adults with obesity or overweight who also had weight-related health problems. The goal was to see if the drug helps with weight loss and is safe. Participants received either ASC30 or a placebo for up to 13 w…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New weight loss drug shows promise in Long-Term Follow-Up study
Disease control CompletedThis study looked at the long-term safety and effectiveness of the drug HRS-7535 for weight management in 81 adults with obesity who had already completed a 36-week treatment course. Participants took the drug for an additional 32 weeks to see how well it helped maintain weight l…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC